3-(Chloromethyl)-2-methylpyridine

Catalog No.: 
ACUMYK817
CAS No.: 
120277-68-1
Molecular Formula: 
C7H8ClN
Molecular Weight: 
141.60
3-(Chloromethyl)-2-methylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$177.00InquiryInquiry
250mg95%$330.00InquiryInquiry
1g95%$825.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Chloromethyl)-2-methylpyridine
IUPAC Name3-(chloromethyl)-2-methylpyridine
MDL No.MFCD10697614
Molecular FormulaC7H8ClN
Molecular Weight141.60
SMILESCC1=NC=CC=C1CCl
InChI KeyDYINCOADXUUIHA-UHFFFAOYSA-N
SynonymPyridine, 3-(chloromethyl)-2-methyl- (9CI);3-(ChloroMethyl)-2-Methylpyridine;2-Methyl-3-(chloromethyl)pyridine;Pyridine, 3-(chloromethyl)-2-methyl-
CAS No.120277-68-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P301+P312

Synthetic Route by SureRoute

1. ACUMYK817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGUXO985 route compound structure diagram
    ACGUXO98556826-61-0In Stock
  2. Then
  3. ACUMYK817 route product structure diagram
    ACUMYK817120277-68-1
Inquiry

2. ACUMYK817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGUXO985 route compound structure diagram
    ACGUXO98556826-61-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUMYK817 route product structure diagram
    ACUMYK817120277-68-1
Inquiry

3. ACUMYK817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGUXO985 route compound structure diagram
    ACGUXO98556826-61-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACUMYK817 route product structure diagram
    ACUMYK817120277-68-1
Inquiry

Comments (0)